ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00996268
Recruitment Status : Completed
First Posted : October 16, 2009
Last Update Posted : June 22, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline